Mindfulness
August 15, 2026
Rosalind McAlpine, Merve Utanğaç, Joanna Kuć et al.
Abstract Objectives Emerging research suggests that meditation may support more beneficial psychedelic experiences while reducing the likelihood of lasting negative effects, yet its specific preparatory benefits remain underexplored. This study aimed to investigate the perceived utility of meditation as a preparatory tool for enhancing positive outcomes and reducing negative effects during...
Journal of psychopharmacology (Oxford, England)
May 23, 2026
Joanna Kuć, Rosalind McAlpine, Amelia Sellers et al.
5-Methoxy-N,N-dimethyltryptamine (5-MeO-DMT), a potent, short-acting psychedelic, induces profound shifts in cognition, affect, and self-awareness. Because language explicitly expresses these domains and voice implicitly conveys them, both may serve as potential 'biomarkers' of behavioural change. This study introduces a novel framework for analysing baseline language and vocal features, pre-...
bioRxiv
April 21, 2025
Joanna Kuć, Rosalind McAlpine, Amelia Sellers et al.
preprint
Abstract 5-MeO-DMT, a potent, short-acting psychedelic, induces profound shifts in cognition, affect, and self-awareness. Because language explicitly expresses these domains and voice implicitly conveys them, both may serve as potential ‘biomarkers’ of behavioural change. This study introduces a novel framework for analysing baseline language and vocal features, pre- to post-psychedelic...
February 6, 2025
Rosalind McAlpine, Merve Utanğaç, Joanna Kuć et al.
2 citations
preprint
The potential of meditation as a preparatory tool for psychedelic experiences lacks empirical investigation. We surveyed experienced practitioners (N=123) with substantial histories in both meditation and psychedelic use to examine meditation’s role in psychedelic preparation. Respondents expected meditation training to primarily enhance acceptance and present-moment focus during psychedelic...